Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

Colorectal cancer screening: health impact and cost effectiveness.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):80-9. Review.

PMID:
16777546
2.

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):72-9. Review.

PMID:
16777545
3.

Priorities among recommended clinical preventive services.

Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH, Haddix A.

Am J Prev Med. 2001 Jul;21(1):1-9.

PMID:
11418251
4.
5.

Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.

Inadomi JM.

J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S198-204. doi: 10.1111/j.1440-1746.2008.05556.x.

PMID:
19120898
6.

Screening of colorectal cancer.

Winawer SJ.

Surg Oncol Clin N Am. 2005 Oct;14(4):699-722. Review.

PMID:
16226687
7.

Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force.

Pignone M, Saha S, Hoerger T, Mandelblatt J.

Ann Intern Med. 2002 Jul 16;137(2):96-104. Review.

PMID:
12118964
8.

Cost-effectiveness of screening the average-risk population for colorectal cancer.

Provenzale D.

Gastrointest Endosc Clin N Am. 2002 Jan;12(1):93-109.

PMID:
11916165
9.

Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States.

Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, Anton-Culver H.

Gastroenterology. 2001 Mar;120(4):848-56.

PMID:
11231939
10.
11.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

12.

Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.

Lejeune C, Arveux P, Dancourt V, Béjean S, Bonithon-Kopp C, Faivre J.

Int J Technol Assess Health Care. 2004 Fall;20(4):434-9.

PMID:
15609792
13.

Potential impact of population-based colorectal cancer screening in Canada.

Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E.

Chronic Dis Can. 2003 Fall;24(4):81-8.

PMID:
14733756
14.

Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.

Heitman SJ, Manns BJ, Hilsden RJ, Fong A, Dean S, Romagnuolo J.

CMAJ. 2005 Oct 11;173(8):877-81.

15.

Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact?

Ladabaum U, Song K, Fendrick AM.

Clin Gastroenterol Hepatol. 2004 Jul;2(7):554-63.

PMID:
15224279
16.

Cost-effectiveness of a single colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F.

Arch Intern Med. 2002 Jan 28;162(2):163-8.

PMID:
11802749
17.

The impact of colorectal cancer screening on life expectancy.

Inadomi JM, Sonnenberg A.

Gastrointest Endosc. 2000 May;51(5):517-23.

PMID:
10805834
18.

Priorities among effective clinical preventive services: results of a systematic review and analysis.

Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI.

Am J Prev Med. 2006 Jul;31(1):52-61. Review.

PMID:
16777543
19.

High participation rates are not necessary for cost-effective colorectal cancer screening.

Howard K, Salkeld G, Irwig L, Adelstein BA.

J Med Screen. 2005;12(2):96-102.

PMID:
15949121
20.

Comparing risks and benefits of colorectal cancer screening in elderly patients.

Ko CW, Sonnenberg A.

Gastroenterology. 2005 Oct;129(4):1163-70.

PMID:
16230070
Items per page

Supplemental Content

Support Center